Advantages of Balanced Crystalloids in the ICU
Balanced crystalloids (lactated Ringer's or Plasma-Lyte) should be used as first-line fluid therapy in critically ill ICU patients because they reduce mortality and major adverse kidney events compared to 0.9% saline. 1
Primary Mortality and Renal Benefits
The landmark SMART trial of 15,802 critically ill adults demonstrated that balanced crystalloids reduced major adverse kidney events (death, new renal replacement therapy, or persistent renal dysfunction) compared to saline (14.3% vs 15.4%, OR 0.91,95% CI 0.84-0.99). 2
Meta-analyses including 35,884 critically ill patients show that balanced crystalloids are associated with reduced mortality in the general ICU population (OR 0.84,95% CI 0.74-0.95). 1
In-hospital mortality trends lower with balanced crystalloids (10.3% vs 11.1%, P=0.06), though this did not reach statistical significance in the primary analysis. 2
Mechanism of Benefit: Prevention of Hyperchloremic Acidosis
Balanced crystalloids have electrolyte compositions closer to plasma (chloride 108-110 mmol/L) compared to saline's supraphysiologic chloride concentration (154 mmol/L), preventing hyperchloremic metabolic acidosis. 3, 1
Hyperchloremic acidosis from high-chloride fluids causes renal vasoconstriction and acute kidney injury, with increased 30-day mortality when hyperchloremia develops. 1
Even relatively small volumes of saline can exert adverse physiological effects on acid-base balance, inflammation, and hemodynamics. 3
Specific ICU Populations with Proven Benefit
Sepsis and Septic Shock
In sepsis patients, balanced crystalloids initiated in the emergency department showed the greatest mortality benefit (OR 0.68,95% CI 0.52-0.89) compared to starting them only after ICU admission. 4, 1
A retrospective cohort of 53,448 septic patients showed lower in-hospital mortality with balanced fluids (19.6% vs 22.8%, RR 0.86,95% CI 0.78-0.94), with a dose-response relationship where larger proportions of balanced fluids correlated with progressively lower mortality. 5
The American College of Emergency Physicians strongly recommends balanced crystalloids as first-line fluid therapy for sepsis. 1
Hemorrhagic Shock and Trauma
European guidelines recommend balanced crystalloids as first-line therapy for hemorrhagic shock, particularly important given the high volumes often required (5,000-10,000 mL in first 24 hours). 6
In trauma patients requiring large volume resuscitation, balanced solutions prevent the compounding acidosis that occurs with both hemorrhagic shock and saline-induced hyperchloremia. 6
Surgical and Perioperative Patients
The World Society of Emergency Surgery recommends balanced crystalloids for emergency laparotomy resuscitation and intravascular volume maintenance. 1
Registry studies show fewer complications with balanced crystalloids compared to saline in major surgery, with a dose-response relationship between saline volume and adverse outcomes. 1
Patients at Risk for Acute Kidney Injury
KDIGO guidelines recommend isotonic crystalloids (preferably balanced) rather than colloids for volume expansion in patients at risk for AKI. 7
The potassium content in lactated Ringer's (4 mmol/L) should not be considered a contraindication in mild-to-moderate hyperkalemia or renal dysfunction—renal transplant recipients receiving saline actually developed higher potassium levels than those receiving lactated Ringer's. 7
Critical Contraindications to Balanced Crystalloids
Traumatic Brain Injury
In patients with severe traumatic brain injury, normal saline should be used instead of balanced crystalloids because the slightly hypotonic nature of lactated Ringer's can worsen cerebral edema (HR 1.78,95% CI 1.04-3.04). 7, 8
A meta-analysis showed lower mortality in TBI patients receiving normal saline compared to balanced crystalloids (RR 1.25,95% CI 1.02-1.54). 8
Rhabdomyolysis and Crush Syndrome
- Avoid balanced crystalloids in suspected or proven rhabdomyolysis due to potassium content; use normal saline instead. 7
Why Colloids Should Be Avoided
Synthetic colloids (hydroxyethyl starch, gelatins) should not be used in ICU patients due to increased renal failure risk (RR 1.34,95% CI 1.0-1.8) without mortality benefit. 6, 1
Hydroxyethyl starch administration is also associated with hemostasis disorders, hemorrhagic risk, and higher transfusion requirements. 6
Albumin shows no mortality benefit compared to crystalloids and costs significantly more, making routine use unjustified. 6
Practical Implementation Algorithm
Step 1: Screen for contraindications
- Severe traumatic brain injury → use normal saline 7
- Rhabdomyolysis/crush syndrome → use normal saline 7
Step 2: If no contraindications present
- Use balanced crystalloids (lactated Ringer's or Plasma-Lyte) as first-line fluid 1
- Initiate in the emergency department rather than waiting for ICU admission for maximum benefit in sepsis 4
Step 3: Monitor during resuscitation
- Target mean arterial pressure ≥65 mmHg, urine output ≥0.5 mL/kg/h, improved mental status and peripheral perfusion 1
- Monitor electrolytes, renal function, and acid-base status 7
- Use advanced monitoring (echocardiography, cardiac output monitoring) when available 1
Step 4: Limit saline use
- If normal saline must be used, limit to maximum 1-1.5 L to minimize chloride load 1
- High volumes of chloride-rich solutions (>5,000 mL) are associated with increased mortality in observational studies 1
Common Pitfalls to Avoid
Do not use outdated protocols from before 2018 that recommend large volume saline resuscitation—this practice is associated with increased mortality and major adverse kidney events. 1
Do not assume potassium in balanced crystalloids is dangerous for renal patients—it is physiologically impossible to create hyperkalemia using a fluid with potassium concentration equal to or lower than plasma. 7
Do not delay switching to balanced crystalloids once in the ICU if saline was started in the ED—early initiation provides the greatest benefit. 4
Do not use synthetic colloids based on theoretical volume expansion advantages—clinical trials show harm without benefit. 6, 1